
The bull market rages on. Many stocks have pulled back from their post-election highs, but the Dow hit a record high closing price and the S&P 500 itself is within 1% of […]
The bull market rages on. Many stocks have pulled back from their post-election highs, but the Dow hit a record high closing price and the S&P 500 itself is within 1% of […]
Stocks were looking for direction on Monday with the Dow slightly in the red and the NASDAQ and S&P 500 barely positive. With a new regime set to lead and make changes […]
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was left for dead earlier in 2024 after formally withdrawing from marketing approval for RELYVRIO/ALBRIOZA in ALS trials. This was nearly a $20 stock in February, and […]